| Company Name |
Kabra Drugs Ltd |
| Face Value |
10 |
| BSE Code |
524322 |
| Year End |
202503 |
| Full Year |
| Equity (Rs.Cr.) |
23.71 |
| B.V. Rs. |
11.00 |
| Sales Rs. Cr. |
0.00 |
| NP Rs. Cr. |
-1.09 |
| NP Var% |
-47.00 |
| Div% |
0.00 |
| CPS Rs. |
-0.50 |
| EPS Rs. |
-0.50 |
| Traded Value(Rs.Lakhs) |
12.62 |
| 52 Week High |
36.00 |
| 52 Week Low |
11.00 |
| Price BSE |
29.00 |
| Price NSE |
0.00 |
| Market Capital(Rs. Cr.) |
68.14 |
| P/C Ratio |
-63.80 |
| P/E Ratio |
-63.30 |
| Price Vs.BV |
2.64 |
| Year End |
202512 |
| Sales Rs. Cr. |
30.42 |
| NP Rs. Cr. |
2.57 |
| NP Var % |
578.00 |
| Year End |
202512 |
| Sales |
0.00 |
| OPM |
0.00 |
| NP |
-1.42 |
| NP Var% |
332.28 |
| EPS |
1.81 |
| PE |
15.88 |
|
|